Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee
Clinical trial NCT03691974 · COMPLETED
Trial details
- NCT number
- NCT03691974
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2020-01-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.